Omeros Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
4,299
Transactions
10,296
2021 Total
$1.6M
Payment Breakdown by Category
Research$2.8M (53.8%)
Consulting$1.4M (26.7%)
Food & Beverage$256,920 (4.9%)
Travel$105,922 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.8M | 249 | 53.8% |
| Consulting Fee | $1.4M | 455 | 26.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $357,914 | 141 | 6.8% |
| Food and Beverage | $256,920 | 8,990 | 4.9% |
| Honoraria | $238,732 | 81 | 4.5% |
| Travel and Lodging | $105,922 | 360 | 2.0% |
| Education | $66,607 | 19 | 1.3% |
| Grant | $3,000 | 1 | 0.1% |
Payments by Type
Research
$2.8M
240 transactions
General
$2.4M
10,047 transactions
Ownership
$0
9 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| OMS721-GNP-001 | $1.2M | 15 | 150 |
| An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients | $636,578 | 0 | 24 |
| OMS 721-TMA-001 | $295,119 | 0 | 10 |
| A Retrospective Study to Determine the Incidence of, Risk Factors for, and Outcomes of Patients with Transplant-Associated Thrombotic Microangiopathy (TA-TMA) After Allogeneic Hematopoietic Cell Transplantation | $268,900 | 0 | 11 |
| OMS302-ILR-007 | $101,490 | 0 | 21 |
| Pain Control and Reduction in Opioid Use | $50,000 | 0 | 2 |
| Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 | $31,549 | 0 | 2 |
| OMS721-TMA-001 | $16,076 | 0 | 15 |
| OMS824-HTD-002 | $2,122 | 0 | 1 |
| OMS182399 | $700.00 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Richard Champlin, M.d, M.D | Hematology & Oncology | Houston, TX | $23,940 | $0 |
| Dr. Jaap-Jan Boelens, Md, Phd, MD, PHD | Pediatric Hematology-Oncology | New York, NY | $20,528 | $0 |
| Dr. Sumithira Vasu, M.d, M.D | Hematology | Columbus, OH | $18,844 | $0 |
| Dr. George Waring, M.d, M.D | Ophthalmology | Mt Pleasant, SC | $17,986 | $0 |
| Michael Scordo | Hematology & Oncology | New York, NY | $17,608 | $0 |
| Brandon Ayres, Md, MD | Ophthalmology | Bala Cynwyd, PA | $17,603 | $0 |
| Savak Teymoorian, M.d, M.D | Ophthalmology | Laguna Hills, CA | $17,524 | $0 |
| Jeffrey Laurence, Md, MD | Hematology & Oncology | New York, NY | $17,117 | $0 |
| Kevin Winthrop, Md, MD | Infectious Disease | Portland, OR | $17,050 | $0 |
| Ara Metjian, Md, MD | Hematology & Oncology | Aurora, CO | $17,010 | $0 |
| John Hovanesian, M.d, M.D | Ophthalmology | Laguna Hills, CA | $16,657 | $0 |
| Richard Lindstrom, M.d, M.D | Ophthalmology | Bloomington, MN | $16,103 | $0 |
| Kenneth Cooke, Md, MD | Pediatrics | Baltimore, MD | $15,146 | $0 |
| James Jerkins, Md, MD | Internal Medicine | Nashville, TN | $15,000 | $0 |
| Thomas Ortel, M.d, M.D | Hematology | Durham, NC | $14,760 | $0 |
| P Dee Stephenson, M.d., P.a, M.D., P.A | Ophthalmology | Venice, FL | $13,850 | $0 |
| Sumitra Khandelwal, Md, MD | Ophthalmology | Houston, TX | $13,749 | $0 |
| David Zuech, M.d, M.D | Ophthalmology | Enid, OK | $13,562 | $0 |
| Dr. Mitchell Cairo, Md, MD | Pediatric Hematology-Oncology | Hawthorne, NY | $12,899 | $0 |
| Dr. Kendall Donaldson, Md, MD | Ophthalmology | Miami, FL | $12,065 | $0 |
| Sangeeta Hingorani, Md, MD | Pediatric Nephrology | Seattle, WA | $12,000 | $0 |
| David Dale, Md, MD | Internal Medicine | Seattle, WA | $12,000 | $0 |
| Dr. William Trattler, Md, MD | Ophthalmology | Miami, FL | $11,815 | $0 |
| Robert Weinstock, Md, MD | Ophthalmology | Largo, FL | $11,372 | $0 |
| Dr. Samer Khaled, M.d, M.D | Internal Medicine | Orlando, FL | $11,363 | $0 |
Ad
Top Products
- Omidria $1.3M
- OMIDRIA $738,978
Associated Products (4)
- Omidria $1.6M
- OMIDRIA $896,672
- Narsoplimab $391,825
- narsoplimab $84,617
Payment Categories
- Food & Beverage $256,920
- Consulting $1.4M
- Travel & Lodging $105,922
- Research $2.8M
About Omeros Corporation
Omeros Corporation has made $5.3M in payments to 4,299 healthcare providers, recorded across 10,296 transactions in the CMS Open Payments database. In 2021, the company paid $1.6M. The top product by payment volume is Omidria ($1.3M).
Payments were distributed across 87 medical specialties. The top specialty by payment amount is Ophthalmology ($1.5M to 2,549 doctors).
Payment categories include: Food & Beverage ($256,920), Consulting ($1.4M), Research ($2.8M), Travel & Lodging ($105,922).
Omeros Corporation is associated with 4 products in the CMS Open Payments database, including Omidria, OMIDRIA, and Narsoplimab.